NvENielka van ErpPharmD, PhDSlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019Drug - Food Interaction an Unrealized Potential - Nielka van Erp, PharmD, PhDView Slideset
SlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019Correlation Between Sunitinib Exposure and Toxicity in a Real-life Patient Cohort - Kim WesterdijkView Slideset
SlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019Influence of Probenecid on the Pharmacokinetics and Pharmacodynamics of Sorafenib - Koen HussaartView Slideset
SKStijn KoolenPharmD, PhDSlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019Dose Individualization Potential for Checkpoint Inhibitors - Stijn Koolen, PharmD, PhDView Slideset
NSNeeltje SteeghsMD, PhDSlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019Dose Individualization Potential for Oral Targeted Oncolytics - Neeltje Steeghs, MD, PhDView Slideset
SlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019Effects of Dietary Restriction in Cancer Patients Receiving Irinotecan - Ruben van EerdenView Slideset
SlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019Pharmacokinetics and Safety of Pazopanib in Frail Elderly Patients - Félicien Le LouedecView Slideset
PLPatricia LoRussoPhDSlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019Optimal Study Design of Oncology Trials - Patricia LoRusso, PhDView Slideset
CJCandice JamoisPharmDSlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019Challenges in the Development of Immunotherapy - Candice Jamois, PharmDView Slideset
SlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019Population Pharmacodynamics Modelling of Circulating Lymphocyte Count Over Time in Chronic Lymphocytic Leukemia Patients Under Ibrutinib Treatment - Fanny GallaisView Slideset
SSStein SchalkwijkPharmD, PhDSlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019Clinical Pharmacology Strategy for Development and Labelling of New Medicine in the Era of Targeted Therapy and Accelerated Approvals in Oncology - Berges & SchalkwijkView Slideset
MKMats KarlssonPhD, FCP, FISoPSlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019Impact of Immortal Time and Selection Bias on Exposure-response Modelling - Mats Karlsson, PhD, FCP, FISoPView Slideset
